Life sciences company EKF Diagnostics Holdings plc (AIM: EKF) has acquired technology assets from Sweden-based Beep Insights AB, including its iOS and Android application designed for real-time glucose and lactate tracking in sports performance monitoring.
The Beep Insights Technology integrates data from Bluetooth-connected wearables with biomarker tracking to deliver personalised training metrics. The acquisition is expected to enhance EKF's existing Sports Performance portfolio, particularly its Lactate Scout Sport handheld analyser, which is already compatible with the application.
EKF has collaborated with Beep Insights and its chief executive officer, Peter Alex, to integrate the software and improve accessibility in determining lactate threshold and optimising training outcomes. Following completion of the transaction, Alex will join EKF to support further development, including the application of artificial intelligence in performance training.
Headquartered in Penarth, Wales, EKF Diagnostics is a global diagnostics business specialising in point-of-care analysers for haematology and diabetes. The company operates manufacturing sites in the US and Germany and serves customers in more than 120 countries.
Asgard Therapeutics appoints chief medical officer
Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting
Senhwa Biosciences secures up to TWD500m funding for AI-driven drug development
hVIVO signs influenza human challenge trial agreement with Traws Pharma
Kazia Therapeutics in-licenses SETDB1 inhibitor drug development platform
Kelun-Biotech reports Phase II study results for sac-TMT at 2026 SGO
Genmab reports positive safety data for Rina-S combination in ovarian cancer